Home » Bayer Teams Up With Canadian Institute for COVID-19 Treatments
Bayer Teams Up With Canadian Institute for COVID-19 Treatments
Bayer is partnering with Canada’s Population Health Research Institute (PHRI) to identify potential COVID-19 treatments.
The institute will evaluate different combination therapies including Bayer’s chloroquine and interferon beta-1b. It plans to enroll 6,000 patients in two studies at more than 60 sites across Ontario and internationally.
Bayer has committed $1 million dollars to the project and will supply the drugs to support the research.
Upcoming Events
-
18Jul
-
21Oct